JD, Temple University School of Law, Philadelphia, Pennsylvania, 2000
MBA, George Washington University, Washington, D.C., 1996
MBA, Kyung Hee University, Seoul, Korea, 1991
BA, Kyung Hee University, Seoul, Korea, 1989
Ted Moon is Managing Director of RM Global Partners (formerly known as “Roberts Mitani”), holds over 17 years of global finance, business development, and law experience. Ted specializes in healthcare and life science sectors.
He has significant cross border experience, especially in managing projects and facilitating investments in U.S., Israel and Korean companies. Ted has built a track record completing numerous innovative life sciences transactions, including over $100 million in private funding for start-ups. He has advised emerging biopharma/medtech venture companies as well as large corporations on their financial and strategic transactions including M&A, capital raising, strategic partnerships, and exit strategies including IPOs.
Ted advised from its inception of AmorePacific Ventures, a strategic corporate venture capital arm of AmorePacific Group, the second largest aesthetics and skin care company in Asia. He successfully completed his assignment as an exclusive sell-side M&A advisor for AmorePacific Group in its sale of pharmaceutical division of PacificPharma, to Handok, another Korean pharmaceutical company.
Ted is managing member of an early stage biopharma focused fund, RMGP Biopharma Fund, investing with a unique biopharma incubator, FutuRx based in Israel, jointly owned and managed by the 3 global biopharma leaders i.e., J&J, Takeda Pharma and Orbimed, with Israel government’s support.
Ted is a board member of The Rogosin Institute, a member hospital affiliated with NY-Presbyterian Hospital and Weill Cornell Medical College, based in New York, NY.
Ted is also an advisory member of Korean Healthcare Industry Development Institute, a Korean government’s agency to support continued growth of the country’s life science and healthcare companies.
Honors & Awards
Author, “What are Leading Trends in Healthcare Technology Collaboration?” New York Health Forum, June 2012
Author, “Corporate Strategic Investment and M&A are the tools small companies can utilize” – Trend, V. 22, KHIDI, October 2013.